257 related articles for article (PubMed ID: 20061641)
1. Neuropathologic alterations in mild cognitive impairment: a review.
Markesbery WR
J Alzheimers Dis; 2010; 19(1):221-8. PubMed ID: 20061641
[TBL] [Abstract][Full Text] [Related]
2. Functional, global and cognitive decline correlates to accumulation of Alzheimer's pathology in MCI and AD.
Sabbagh MN; Cooper K; DeLange J; Stoehr JD; Thind K; Lahti T; Reisberg B; Sue L; Vedders L; Fleming SR; Beach TG
Curr Alzheimer Res; 2010 Jun; 7(4):280-6. PubMed ID: 19715548
[TBL] [Abstract][Full Text] [Related]
3. Neuropathologic substrate of mild cognitive impairment.
Markesbery WR; Schmitt FA; Kryscio RJ; Davis DG; Smith CD; Wekstein DR
Arch Neurol; 2006 Jan; 63(1):38-46. PubMed ID: 16401735
[TBL] [Abstract][Full Text] [Related]
4. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologic features of amnestic mild cognitive impairment.
Petersen RC; Parisi JE; Dickson DW; Johnson KA; Knopman DS; Boeve BF; Jicha GA; Ivnik RJ; Smith GE; Tangalos EG; Braak H; Kokmen E
Arch Neurol; 2006 May; 63(5):665-72. PubMed ID: 16682536
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's-type neuropathology in the precuneus is not increased relative to other areas of neocortex across a range of cognitive impairment.
Nelson PT; Abner EL; Scheff SW; Schmitt FA; Kryscio RJ; Jicha GA; Smith CD; Patel E; Markesbery WR
Neurosci Lett; 2009 Feb; 450(3):336-9. PubMed ID: 19010392
[TBL] [Abstract][Full Text] [Related]
8. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
9. [Concept and clinical presentation of mild cognitive impairment].
Hanyu H
Brain Nerve; 2010 Jul; 62(7):719-25. PubMed ID: 20675876
[TBL] [Abstract][Full Text] [Related]
10. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease.
Whitwell JL; Przybelski SA; Weigand SD; Knopman DS; Boeve BF; Petersen RC; Jack CR
Brain; 2007 Jul; 130(Pt 7):1777-86. PubMed ID: 17533169
[TBL] [Abstract][Full Text] [Related]
11. The neuropathology of probable Alzheimer disease and mild cognitive impairment.
Schneider JA; Arvanitakis Z; Leurgans SE; Bennett DA
Ann Neurol; 2009 Aug; 66(2):200-8. PubMed ID: 19743450
[TBL] [Abstract][Full Text] [Related]
12. Thal Amyloid Stages Do Not Significantly Impact the Correlation Between Neuropathological Change and Cognition in the Alzheimer Disease Continuum.
Serrano-Pozo A; Qian J; Muzikansky A; Monsell SE; Montine TJ; Frosch MP; Betensky RA; Hyman BT
J Neuropathol Exp Neurol; 2016 Jun; 75(6):516-26. PubMed ID: 27105663
[TBL] [Abstract][Full Text] [Related]
13. Cognitive composite score association with Alzheimer's disease plaque and tangle pathology.
Malek-Ahmadi M; Chen K; Perez SE; He A; Mufson EJ
Alzheimers Res Ther; 2018 Sep; 10(1):90. PubMed ID: 30205840
[TBL] [Abstract][Full Text] [Related]
14. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.
Riley KP; Snowdon DA; Markesbery WR
Ann Neurol; 2002 May; 51(5):567-77. PubMed ID: 12112102
[TBL] [Abstract][Full Text] [Related]
16. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
Haroutunian V; Purohit DP; Perl DP; Marin D; Khan K; Lantz M; Davis KL; Mohs RC
Arch Neurol; 1999 Jun; 56(6):713-8. PubMed ID: 10369312
[TBL] [Abstract][Full Text] [Related]
17. Is there a neuropathology difference between mild cognitive impairment and dementia?
Haroutunian V; Hoffman LB; Beeri MS
Dialogues Clin Neurosci; 2009; 11(2):171-9. PubMed ID: 19585952
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment.
Dugger BN; Davis K; Malek-Ahmadi M; Hentz JG; Sandhu S; Beach TG; Adler CH; Caselli RJ; Johnson TA; Serrano GE; Shill HA; Belden C; Driver-Dunckley E; Caviness JN; Sue LI; Jacobson S; Powell J; Sabbagh MN
BMC Neurol; 2015 Aug; 15():146. PubMed ID: 26289075
[TBL] [Abstract][Full Text] [Related]
19. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
20. Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Guillozet AL; Weintraub S; Mash DC; Mesulam MM
Arch Neurol; 2003 May; 60(5):729-36. PubMed ID: 12756137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
